Gene · 9112
Papers2,013
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,013
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2022 | 35884472 | PubTator, text mining | PubMed |
| Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code. | Cancers (Basel) | 2022 | 35884464 | PubTator, text mining | PubMed |
| Gene regulation by histone-modifying enzymes under hypoxic conditions: a focus on histone methylation and acetylation. | Exp Mol Med | 2022 | 35869366 | PubTator, text mining | PubMed |
| TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression. | Int J Biol Sci | 2022 | 35864973 | PubTator, text mining | PubMed |
| Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia. | Blood | 2022 | 35839448 | PubTator, text mining | PubMed |
| Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer. | Front Oncol | 2022 | 35832561 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| The intrinsically disordered protein TgIST from Toxoplasma gondii inhibits STAT1 signaling by blocking cofactor recruitment. | Nat Commun | 2022 | 35831295 | PubTator, text mining | PubMed |
| SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk. | Cancer Discov | 2022 | 35819319 | PubTator, text mining | PubMed |
| Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy. | Front Oncol | 2022 | 35814468 | PubTator, text mining | PubMed |
| Epigenetic Alterations in Cryopreserved Human Spermatozoa: Suspected Potential Functional Defects. | Cells | 2022 | 35805194 | PubTator, text mining | PubMed |
| Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story. | Cancers (Basel) | 2022 | 35805007 | PubTator, text mining | PubMed |
| Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer. | Cancers (Basel) | 2022 | 35804965 | PubTator, text mining | PubMed |
| Distinct biochemical properties of the class I histone deacetylase complexes. | Curr Opin Chem Biol | 2022 | 35803024 | PubTator, text mining | PubMed |
| Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. | World J Gastroenterol | 2022 | 35800182 | PubTator, text mining | PubMed |
| Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. | Signal Transduct Target Ther | 2022 | 35798726 | PubTator, text mining | PubMed |
| Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune Responses. | Front Immunol | 2022 | 35795673 | PubTator, text mining | PubMed |
| MTA1: A Vital Modulator in Prostate Cancer. | Curr Protein Pept Sci | 2022 | 35792131 | PubTator, text mining | PubMed |
| Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy. | Cancer Commun (Lond) | 2022 | 35791509 | PubTator, text mining | PubMed |
| TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | EMBO Rep | 2022 | 35785414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9112/papers?page=18